Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$32.2 - $42.44 $815,271 - $1.07 Million
-25,319 Reduced 55.76%
20,088 $646,000
Q4 2023

Feb 14, 2024

BUY
$31.87 - $40.71 $706,175 - $902,052
22,158 Added 95.31%
45,407 $1.85 Million
Q3 2023

Nov 14, 2023

BUY
$34.17 - $42.98 $793,700 - $998,339
23,228 Added 110609.52%
23,249 $803,000
Q2 2023

Aug 14, 2023

SELL
$37.4 - $44.52 $643,055 - $765,476
-17,194 Reduced 99.88%
21 $0
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $594,804 - $782,208
16,296 Added 1773.23%
17,215 $665,000
Q4 2022

Feb 14, 2023

SELL
$37.44 - $46.51 $83,828 - $104,135
-2,239 Reduced 70.9%
919 $40,000
Q3 2022

Nov 14, 2022

SELL
$42.27 - $57.6 $1.6 Million - $2.19 Million
-37,969 Reduced 92.32%
3,158 $135,000
Q2 2022

Aug 15, 2022

SELL
$52.3 - $71.59 $246,751 - $337,761
-4,718 Reduced 10.29%
41,127 $2.3 Million
Q1 2022

May 16, 2022

BUY
$51.32 - $68.5 $477,840 - $637,803
9,311 Added 25.49%
45,845 $2.84 Million
Q4 2021

Feb 14, 2022

SELL
$47.03 - $57.12 $244,038 - $296,395
-5,189 Reduced 12.44%
36,534 $2.01 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $219,166 - $294,910
4,201 Added 11.2%
41,723 $2.2 Million
Q2 2021

Aug 16, 2021

BUY
$68.86 - $83.34 $1.45 Million - $1.76 Million
21,071 Added 128.08%
37,522 $2.59 Million
Q1 2021

May 17, 2021

BUY
$76.15 - $111.94 $135,013 - $198,469
1,773 Added 12.08%
16,451 $1.27 Million
Q4 2020

Feb 16, 2021

BUY
$96.85 - $148.25 $1.42 Million - $2.18 Million
14,678 New
14,678 $1.45 Million
Q2 2020

Aug 14, 2020

SELL
$185.52 - $231.25 $674,736 - $841,056
-3,637 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$143.0 - $274.03 $287,144 - $550,252
-2,008 Reduced 35.57%
3,637 $713,000
Q4 2019

Feb 14, 2020

BUY
$146.12 - $215.82 $522,525 - $771,772
3,576 Added 172.84%
5,645 $1.17 Million
Q3 2019

Nov 14, 2019

BUY
$130.44 - $187.64 $56,089 - $80,685
430 Added 26.24%
2,069 $316,000
Q2 2019

Aug 14, 2019

BUY
$111.45 - $128.93 $182,666 - $211,316
1,639 New
1,639 $211,000
Q1 2019

May 15, 2019

SELL
$89.61 - $117.78 $383,710 - $504,333
-4,282 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$87.81 - $110.65 $62,257 - $78,450
709 Added 19.84%
4,282 $393,000
Q3 2018

Nov 14, 2018

BUY
$90.63 - $120.22 $323,820 - $429,546
3,573 New
3,573 $402,000
Q4 2017

Feb 14, 2018

SELL
$84.48 - $104.02 $296,778 - $365,422
-3,513 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$73.17 - $103.47 $257,046 - $363,490
3,513
3,513 $357,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.69B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.